Form 4: BiomX CEO Jonathan Solomon Receives Stock Options and Restricted Stock Units

BiomX Inc. CEO Jonathan Eitan Solomon reports the acquisition of stock options and restricted stock units (RSUs) in the company.

Summary

• On April 14, 2025, Jonathan Eitan Solomon, CEO of BiomX Inc., was granted 126,748 Restricted Stock Units (RSUs).
• These RSUs are immediately vested and convert into shares of common stock on a one-for-one basis.
• Solomon also acquired options to purchase 380,500 shares of BiomX common stock at an exercise price of $0.538.
• The options vest over four years, with 25% vesting on April 14, 2026, and the remainder vesting in 12 equal quarterly installments over three years.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of equity compensation is a standard practice, and the vesting schedule suggests a focus on long-term growth. There are no immediate negative implications.

Positives

• The grant of RSUs and stock options to the CEO aligns his interests with those of the shareholders.
• The vesting schedule of the options incentivizes long-term performance.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the options.

Industry Context

This type of equity compensation is common in the biotech industry to attract and retain top executive talent and align their interests with company performance.

Comparison to Industry Standards

• Equity compensation packages for CEOs in the biotech industry typically include a mix of stock options and restricted stock units.
• The vesting schedules are designed to incentivize long-term value creation, often spanning three to five years.
• The specific amounts and terms vary based on company size, stage of development, and individual performance.

Stakeholder Impact

• Shareholders may view the equity compensation positively as it aligns management's interests with long-term value creation.
• Employees may see it as a sign of confidence in the company's future.

Key Dates

Keywords

BiomX, Jonathan Solomon, CEO, stock options, restricted stock units, RSUs, Form 4, beneficial ownership, equity securities, vesting